| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0008 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.55 | 0.0008 |